Pharmaceutical preparations company · DE · FY ends Dec · -11910.14% margin · -$42M FCF
The business is unprofitable at the operating level (-11910.14% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
ROIC dropped from -58.47% to -63.83%, capital efficiency is deteriorating. Net debt of $37M represents 43.0x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (FY)
$789K
Net Income (TTM)
-$47M
▲ +4088.2% YoY
Op. Margin
-11910.14%
ROIC
-57.28%
▼ -5.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$42M
▲ +100.6% YoY
Op. Cash Flow (TTM)
-$42M
▲ +100.8% YoY
Net Debt
$51M
Cash & Equiv.
$30M
5Y CAGR: -52.7%
Continue Research